WHO recommendations : Uterotonics for the prevention of postpartum haemorrhage / World Health Organization.

Format:

Book

Author/Creator:

World Health Organization, author, issuing body.

Language:

English

Subjects (All):

Postnatal care.

Physical Description:

1 online resource (ix, 43 pages)

Place of Publication:

Geneva : World Health Organization, 2018.

Summary:

The primary goal of this guideline is to provide a foundation for the implementation of interventions shown to have been effective in reducing the burden of PPH (postpartum haemorrhage). Health professionals responsible for developing national and local health policies constitute the main target audience of this document. Obstetricians, midwives, general medical practitioners, health care managers and public health policy-makers, particularly in under-resourced settings are also targeted. This document establishes general principles of PPH care and it is intended to inform the development of clinical protocols and health policies related to PPH.

Contents:

Acknowledgements

Acronyms and abbreviations

Executive summary

1. Introduction

1.1. Background

1.2. Aim

1.3. Target audience

1.4. Scope of the recommendations

2. Methods

2.1. Executive Guideline Steering Group (2017-2019)

2.2. WHO Steering Group

2.3. Guideline Development Group (GDG)

2.4. Evidence Synthesis Group (ESG)

2.5. Observers

2.6. External Review Group (ERG)

2.7. Identification of priority questions and outcomes

2.8. Evidence identification and retrieval

2.9. Quality assessment and grading of the evidence

2.10. Formulation of recommendations

2.11. Decision-making during the GDG meetings

2.12. Management of declarations of interests

2.13. Document preparation and peer review

3. Recommendations and supporting evidence

3.1. Guiding principles

3.2. Recommendations

4. Dissemination and implementation of the recommendations

4.1. Dissemination and evaluation

4.2. Implementation considerations

5. Research implications

6. Applicability issues

6.1. Anticipated impact on the organization of care and resources

6.2. Monitoring and evaluating guideline implementation

7. Updating the recommendations

8. References

Annex 1. External experts and WHO staff involved in the preparation of the recommendations

Annex 2. Priority outcomes used in decision-making

Annex 3. Summary and management of declared interests from GDG members

Web annex 1. Oxytocin versus placebo or no treatment: Evidence to Decision framework

Web annex 2. Carbetocin versus placebo or no treatment: Evidence to Decision framework

Web annex 3. Misoprostol versus placebo or no treatment: Evidence to Decision framework

Web annex 4. Ergometrine/methylergometrine versus placebo or no treatment

Web annex 5. Oxytocin and ergometrine versus placebo or no treatment: Evidence to Decision framework

Web annex 6. Injectable prostaglandins versus placebo or no treatment: Evidence to Decision Framework

Web annex 7. Choice of uterotonic agents: Evidence to Decision framework.

Notes:

Description based on publisher supplied metadata and other sources.